Global Custom Assays Market Growth (Status and Outlook) 2023-2029

Global Custom Assays Market Growth (Status and Outlook) 2023-2029

Custom assay is a type of cell or biochemical base provided by assay kits manufacturers to their customers when requested in order to fulfill their needs and purposes.

LPI (LP Information)' newest research report, the “Custom Assays Industry Forecast” looks at past sales and reviews total world Custom Assays sales in 2022, providing a comprehensive analysis by region and market sector of projected Custom Assays sales for 2023 through 2029. With Custom Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Custom Assays industry.

This Insight Report provides a comprehensive analysis of the global Custom Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Custom Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Custom Assays market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Custom Assays and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Custom Assays.

The global Custom Assays market size is projected to grow from US$ 35890 million in 2022 to US$ 50710 million in 2029; it is expected to grow at a CAGR of 5.1% from 2023 to 2029.

United States market for Custom Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Custom Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Custom Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Custom Assays players cover Thermo Fisher Scientific, Bio-Rad, Roche Life Science, Fluidigm, Promega, Merck, GE Healthcare Lifescience, Cisbio and Biosensorix, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Custom Assays market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Activity Assays
Competitive Assays
ELISA Assays
Screening Assays
Others

Segmentation by application
Academic & Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Contract Research Organizations
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Bio-Rad
Roche Life Science
Fluidigm
Promega
Merck
GE Healthcare Lifescience
Cisbio
Biosensorix
ProeoGenix
Ethos Biosciences
Abzena
Agena Bioscience
Agilent
TissueMetrics
Eurofins Scientific
BioGenes GmbH
Eve Technologies
Quansys Bioscience

Please note: The report will take approximately 2 business days to prepare and deliver.